Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Bode

Showing results (581-590 of 600) with videos related to

Pageof 60
Sort By:
Circulation Research|July 22, 2015
Adrenergic Repression of the Epigenetic Reader MeCP2 Facilitates Cardiac Adaptation in Chronic Heart FailureSandra C Mayer, Ralf Gilsbach, Sebastian Preissl, et al.
Journal of Lipid and Atherosclerosis|June 3, 2022
Effects of Short Term Adiponectin Receptor Agonism on Cardiac Function and Energetics in Diabetic <i>db/db</i> MiceAleksandre Tarkhnishvili, Christoph Koentges, Katharina Pfeil, et al.
Basic Research in Cardiology|February 20, 2016
Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progressionAlexandra Lindau, Carmen Härdtner, Sonja P Hergeth, et al.
Journal of Molecular and Cellular Cardiology Plus|June 30, 2025
Sirtuin 4 accelerates heart failure development by enhancing reactive oxygen species-mediated profibrotic transcriptional signalingNikole J Byrne, Christoph Koentges, Elisabeth Khan, et al.
Acta Physiologica (Oxford, England)|October 17, 2025
Cardiomyocyte-Specific Deletion of Sirtuin 5 Accelerates the Development of Heart Failure Upon Dysregulating Purine MetabolismNikole J Byrne, Christoph Koentges, Katharina Pfeil, et al.
JAMA|September 1, 2014
Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trialMichelle L O'Donoghue, Eugene Braunwald, Harvey D White, et al.
Lancet (London, England)|March 23, 2017
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trialE Magnus Ohman, Matthew T Roe, P Gabriel Steg, et al.
Nature Communications|February 8, 2018
A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defenseDennis Wolf, Nathaly Anto-Michel, Hermann Blankenbach, et al.
Basic Research in Cardiology|December 9, 2020
Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol loweringCarmen Härdtner, Jan Kornemann, Katja Krebs, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 5, 2021
Genetic Deficiency of TRAF5 Promotes Adipose Tissue Inflammation and Aggravates Diet-Induced Obesity in MiceMark Colin Gissler, Nathaly Anto-Michel, Jan Pennig, et al.
Pageof 60

Showing results (581-590 of 600) with videos related to

Sort By:
Pageof 60
Circulation Research|July 22, 2015
Adrenergic Repression of the Epigenetic Reader MeCP2 Facilitates Cardiac Adaptation in Chronic Heart FailureSandra C Mayer, Ralf Gilsbach, Sebastian Preissl, et al.
Journal of Lipid and Atherosclerosis|June 3, 2022
Effects of Short Term Adiponectin Receptor Agonism on Cardiac Function and Energetics in Diabetic <i>db/db</i> MiceAleksandre Tarkhnishvili, Christoph Koentges, Katharina Pfeil, et al.
Basic Research in Cardiology|February 20, 2016
Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progressionAlexandra Lindau, Carmen Härdtner, Sonja P Hergeth, et al.
Journal of Molecular and Cellular Cardiology Plus|June 30, 2025
Sirtuin 4 accelerates heart failure development by enhancing reactive oxygen species-mediated profibrotic transcriptional signalingNikole J Byrne, Christoph Koentges, Elisabeth Khan, et al.
Acta Physiologica (Oxford, England)|October 17, 2025
Cardiomyocyte-Specific Deletion of Sirtuin 5 Accelerates the Development of Heart Failure Upon Dysregulating Purine MetabolismNikole J Byrne, Christoph Koentges, Katharina Pfeil, et al.
JAMA|September 1, 2014
Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trialMichelle L O'Donoghue, Eugene Braunwald, Harvey D White, et al.
Lancet (London, England)|March 23, 2017
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trialE Magnus Ohman, Matthew T Roe, P Gabriel Steg, et al.
Nature Communications|February 8, 2018
A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defenseDennis Wolf, Nathaly Anto-Michel, Hermann Blankenbach, et al.
Basic Research in Cardiology|December 9, 2020
Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol loweringCarmen Härdtner, Jan Kornemann, Katja Krebs, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 5, 2021
Genetic Deficiency of TRAF5 Promotes Adipose Tissue Inflammation and Aggravates Diet-Induced Obesity in MiceMark Colin Gissler, Nathaly Anto-Michel, Jan Pennig, et al.
Pageof 60